Blog

Buying health insurance is really important to protect against financial loss. But when you start to shop for policies, you may be overwhelmed by the options.

One of these may be a short-term health

Shares of NovoCure (NASDAQ: NVCR), which makes devices for treating cancerous solid tumors with electric fields, rocketed 28.7% last month, according to data from S&P Global Market Intelligence. For

Shares of EPAM Systems (NYSE: EPAM), a leading provider of digital platform engineering and software development services, soared 20.4% last month, according to data from S&P Global Market

Google parent Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) is under new management. Co-founders Larry Page and Sergey Brin have relinquished their titles and job functions as CEO and president

If finding a top dividend stock were as easy as just looking at the yield, we'd all be rich. There are always a bunch of high yielders trading on the stock market -- some at bargain-basement prices!

Image source: The Motley Fool.

HealthEquity Inc (NASDAQ: HQY)Q3 2020 Earnings CallDec 3, 2019, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

With so many people cutting the cord to cable, it seems an odd time for Sony (NYSE: SNE) and Walmart (NYSE: WMT) to exit streaming video. Seemingly almost every network and studio wants to get into

When the year began, it appeared as if cannabis stocks could do no wrong. The first quarter featured over a dozen pot stocks that gained at least 70%, with the Horizons Marijuana Life Sciences ETF

Stashing money away in your 401(k) for years on end, sadly, does not guarantee a fruitful retirement. Just look at the numbers. Fidelity reports that the average 401(k) balance in 2018 was $102,900

With the cryptocurrency crash, China trade war, and the quickly changing technology landscape, NVIDIA (NASDAQ: NVDA) and Advanced Micro Devices (NASDAQ: AMD) have had a volatile 2019. But by staying

Shares of Roku (NASDAQ: ROKU) tanked on Monday after Morgan Stanley said it was time to sell, citing concerns around valuation and slowing growth. Needham countered that downgrade on Tuesday with a

So you want a stock for your retirement portfolio with a good dividend yield -- well covered by earnings and free cash flow -- and you want to buy it on a good valuation too? Look no further than

What a difference half a year makes.

Earlier this year, it was as if marijuana stocks could do no wrong, and Quebec-based HEXO (NYSE: HEXO) was among those leading the pack. Having transferred from

Breaking up Amazon.com (NASDAQ: AMZN) to diminish its power is not a new idea -- activists and politicians of both parties have advocated it for years. While support for the suggestion hasn't really

The People's Bank of China (PBOC) has been developing a state-backed cryptocurrency over the past five years. But unlike decentralized blockchain-based cryptocurrencies, which enable anonymous

When the curtain eventually closes on the stock market in 2019, it's probably going to be one of the best years on record. Through this past weekend, the iconic Dow Jones Industrial Average had

With the new year being right around the corner, many people will no doubt start making their lists of financial resolutions. And chances are, "save more money" will be one of yours. If you're eager

Tesla's (NASDAQ: TSLA) new Cybertruck was met with skepticism when it was unveiled last week. Nevertheless, many consumers seem to have warmed up to the vehicle, with reservations rising to 250,000

Shares of Carvana (NYSE: CVNA) surged last month, as the high-flying disruptive car dealer overcome a disappointing earnings report and got a boost from an apparent short squeeze in the second half

Shares of BioMarin Pharmaceutical (NASDAQ: BMRN) rose more than 10% last month, according to data from S&P Global Market Intelligence. The rare-disease specialist reported promising results from an

Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) gained more than 13% last month, according to data from S&P Global Market Intelligence. The monthly surge continued a sudden end-of-year rally for the

Shares of Editas Medicine (NASDAQ: EDIT) rose more than 45% last month, according to data from S&P Global Market Intelligence. The gene editing pioneer rose for reasons both internal and external. 

In this episode of MarketFoolery, Chris Hill talks with The Motley Fool's Dan Kline about some of today's business news. The holiday shopping season is in full swing, and sales numbers look like

In this week's episode of Rule Breaker Investing, David Gardner shares something old, something new, something borrowed, and something blue. Some of the many topics covered:

And much more. To catch

Ouch! Tuesday was a day full of pain for investors in top stocks, with the markets sliding downward into the dirt. Very few stocks were spared.

On such a day, it's hard to find any success stories